Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.31% is 99% below its 5-year average of 33.98%, near the low end of its 5-year range (0.29%–66.96%).
As of the fiscal period ended Tuesday, June 30, 2026. 96.41% below its 12-month average of 8.73%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.31%.
DEBT TO ASSETS RATIO
0.31%
DEBT TO ASSETS RATIO AVG TTM
8.73%
DEBT TO ASSETS RATIO AVG 3Y
26.71%
DEBT TO ASSETS RATIO AVG 5Y
33.98%
DEBT TO ASSETS RATIO AVG 10Y
39.24%
DEBT TO ASSETS RATIO AVG 15Y
45.39%
DEBT TO ASSETS RATIO AVG 20Y
38.45%
CURRENT VS TTM AVG
-96.41%
CURRENT VS 3Y AVG
-98.83%
CURRENT VS 5Y AVG
-99.08%
CURRENT VS 10Y AVG
-99.20%
CURRENT VS 15Y AVG
-99.31%
CURRENT VS 20Y AVG
-99.18%
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 465 covered companies
CURRENT VS SECTOR MEDIAN
+185.10%
vs the sector median at left
Cerenome, Inc.
Market Cap
$10.74M
Debt to Assets Ratio
0.31%
TTM Avg
8.73%
3Y Avg
26.71%
5Y Avg
33.98%
Market Cap
$11.01M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.27M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.07M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.42M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.95M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cerenome, Inc. (CNSY) | $10.74M | 0.31% | 8.73% | 26.71% | 33.98% |
| BioVie Inc. (BIVI)vs › | $10.86M | 0.02% | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.01M | 0.01% | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.27M | 0.00% | N/A | N/A | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $10.07M | 0.00% | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.41M | 0.31% | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.42M | 0.00% | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.79M | 0.71% | N/A | N/A | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.95M | 0.06% | N/A | N/A | N/A |
| HeartSciences Inc. (HSCS)vs › | $9.42M | 1.07% | N/A | N/A | N/A |
Debt/Assets
0.3%
Debt/Equity
0.01
Current Ratio
1.37
Interest Coverage
-4.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.31% |
| 2026-03-31 | 3.64% |
| 2025-12-31 | 5.03% |
| 2025-09-30 | 34.39% |
| 2025-06-30 | 0.29% |
| 2025-03-31 | 0.33% |
| 2024-12-31 | 50.76% |
| 2024-09-30 | 48.72% |
| 2024-06-30 | 30.63% |
| 2024-03-31 | 66.96% |
| 2023-12-31 | 36.71% |
| 2023-09-30 | 34.52% |
| 2023-06-30 | 34.90% |
| 2023-03-31 | 34.08% |
| 2022-12-31 | 24.11% |
| 2022-09-30 | 26.41% |
| 2022-06-30 | 30.26% |
| 2022-03-31 | 27.66% |
| 2021-12-31 | 31.81% |
| 2021-09-30 | 29.75% |
| 2021-06-30 | 34.92% |
| 2021-03-31 | 38.73% |
| 2020-12-31 | 57.79% |
| 2020-09-30 | 58.92% |
| 2020-06-30 | 48.58% |
| 2020-03-31 | 56.96% |
| 2019-12-31 | 51.54% |
| 2019-09-30 | 45.80% |
| 2019-06-30 | 131.90% |
| 2019-03-31 | 67.39% |
| 2018-12-31 | 59.20% |
| 2018-09-30 | 54.86% |
| 2018-06-30 | 61.01% |
| 2018-03-31 | 51.53% |
| 2017-12-31 | 43.09% |
| 2017-09-30 | 51.04% |
| 2017-06-30 | 44.69% |
| 2017-03-31 | 54.03% |
| 2016-12-31 | 50.96% |
| 2016-09-30 | 47.22% |
| 2016-06-30 | 40.20% |
| 2016-03-31 | 51.41% |
| 2015-12-31 | 44.25% |
| 2015-09-30 | 38.69% |
| 2015-06-30 | 34.84% |
| 2015-03-31 | 69.31% |
| 2014-12-31 | 65.61% |
| 2014-09-30 | 79.87% |
| 2014-06-30 | 70.18% |
| 2014-03-31 | 67.39% |
| 2013-12-31 | 62.51% |
| 2013-09-30 | 73.86% |
| 2013-06-30 | 64.73% |
| 2013-03-31 | 61.12% |
| 2012-12-31 | 52.46% |
| 2012-09-30 | 77.93% |
| 2012-06-30 | 61.18% |
| 2012-03-31 | 50.13% |
| 2011-12-31 | 47.44% |
| 2011-09-30 | 43.69% |
| 2011-06-30 | 37.02% |
| 2011-03-31 | 35.02% |
| 2010-12-31 | 29.70% |
| 2010-09-30 | 44.85% |
| 2010-06-30 | 38.04% |
| 2010-03-31 | 13.92% |
| 2009-12-31 | 33.48% |
| 2009-09-30 | 24.13% |
| 2009-06-30 | 25.46% |
| 2009-03-31 | 25.37% |
| 2008-12-31 | 27.69% |
| 2008-09-30 | 1.81% |
| 2008-06-30 | 3.61% |
| 2008-03-31 | 4.27% |
| 2007-12-31 | 4.45% |
| 2007-09-30 | 3.92% |
| 2007-06-30 | 3.76% |
| 2007-03-31 | 5.25% |
| 2006-12-31 | 8.68% |
| 2006-09-30 | 5.82% |
| 2006-06-30 | 13.14% |
| 2006-03-31 | 7.05% |
| 2005-12-31 | 8.91% |
| 2005-09-30 | 6.37% |
| 2005-06-30 | 6.03% |
| 2005-03-31 | 8.83% |
| 2004-12-31 | 8.11% |
| 2004-09-30 | 7.68% |
| 2004-06-30 | 7.15% |
| 2004-03-31 | 8.03% |
| 2003-12-31 | 9.22% |
| 2003-09-30 | 4.33% |
| 2003-06-30 | 3.09% |
| 2003-03-31 | 3.18% |
| 2002-12-31 | 3.00% |
| 2002-09-30 | 5.21% |
